Работы, цитирующие эту работу

Работ: 3

Работа: 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

1. TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice

   Krzysztof J. Filipiak‬, Miguel Camafort, Matteo Cameli +9

   СтатьяLipoproteins and Cardiovascular HealthCardiology Journal2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.article.001294

2. Prevention of cardiovascular disease in young adults: Focus on gender differences. A collaborative review from the EAS Young Fellows

   Christina Antza, Antonio Gallo, Chrysoula Boutari +7

   Обзорная статьяObesity, Physical Activity, DietAtherosclerosis2023Цитирований: 0

   ABIABI:AkademIndex/openalex/2023.review-article.000026

3. Advancements in risk stratification and management strategies in primary cardiovascular prevention

   Fotios Barkas, Yusuf Ziya Şener, Pelin Golforoush +25

   Обзорная статьяLipoproteins and Cardiovascular HealthAtherosclerosis2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.review-article.000004